From: Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs
Characteristics | Number | |
---|---|---|
Age, years | ||
Median (range) | 67 | (54–86) |
Sex | ||
Male/female | 18/15 | |
Performance status | ||
0/1/2 | 2/28/3 | |
Clinical stage | ||
III/IV | 6/27 | |
Histology | ||
Ad/Sq/La | 29/3/1 | |
EGFR mutation status | ||
Ex18 del/ Ex19 del/ Ex21L858R | 1/9/9 | |
Negative | 9 | |
Unknown | 5 | |
Brinkman index | ||
Median (range) | 370 | (0–3840) |
Body mass index, Kg/m2 | ||
Median (range) | 23.0 | (16.0–29.8) |
Concomitant disease | ||
rheumatoid arthritis | 1 | |
diabetes mellitus | 6 | |
hyperlipidemia | 6 | |
hypertension | 17 | |
Treatment line | ||
1st/2nd/more | 3/19/11 |